Frozen Tissue Samples Market Overview
The Frozen Tissue Samples Market is expanding as demand for biobanking, cancer research, genomics, personalized medicine, and advanced biological sample preservation continues to increase. Improvements in cryopreservation technologies, automated storage, sample tracking, and processing are enhancing the reliability and accessibility of frozen tissue samples for research institutions and clinical laboratories.
The market was valued at USD 1.9 billion in 2024 and is projected to reach USD 3.0 billion by 2035, growing at a 4.4% CAGR during 2026–2035. North America is the leading regional market, valued at USD 900 million in 2024 and projected to reach USD 1.4 billion by 2035. Cancer Research is the leading application, increasing from USD 800 million in 2024 to USD 1.2 billion by 2035, while Asia-Pacific is expected to be the fastest-growing region.
Unlock Exclusive Insights – Request Your Free Sample Report Now!
https://www.wiseguyreports.com/reports/frozen-tissues-samples-market
Key Players
Fisher BioServices, ZenBio, CRL, Tissue Solutions, ABT Molecular Imaging, ASR Health Services, Biosample Solutions, Thermo Fisher Scientific, LabCorp, Epitomics, Eurac Research, The BioCollection, BioIVT, and Charles River Laboratories are among the key companies profiled in the Frozen Tissue Samples Market.
Market Drivers and Trends
The rising demand for cancer research is a major market driver. Frozen tissue samples provide researchers with biological material for studying tumor biology, evaluating therapies, developing diagnostics, and investigating disease mechanisms.
Advancements in biobanking and cryopreservation technologies are improving the long-term preservation, recovery, and integrity of biological samples. These developments are supporting wider use of frozen tissues in genomics, pharmaceutical research, and clinical studies.
The growing focus on personalized and precision medicine is creating additional demand for high-quality patient-derived tissue samples. Pharmaceutical and research organizations increasingly rely on biological samples to understand individual disease characteristics and therapeutic responses.
Integrated sample-management systems are becoming more important as biobanks seek better tracking, inventory management, quality control, and data integration. Digital technologies are helping researchers improve access to and analysis of stored biological materials.
Market Segmentation
By application, the market is segmented into Cancer Research, Genetic Research, Drug Development, and Diagnostic Applications. Cancer Research is the dominant application, valued at USD 800 million in 2024 and projected to reach USD 1.2 billion by 2035.
By end use, the market includes Academic Institutions, Pharmaceutical Companies, Biotechnology Companies, and Clinical Research Organizations. Academic institutions represent a major utilization base, while pharmaceutical and biotechnology companies use frozen samples extensively for drug development and molecular research.
By sample type, the market covers Tumor Samples, Normal Tissue Samples, Peripheral Blood Mononuclear Cells, and Bone Marrow Samples. Tumor samples are particularly important for oncology research, while peripheral blood mononuclear cells support immunological studies and bone marrow samples are important in hematological research.
By storage method, the market comprises Liquid Nitrogen Freezers, Mechanical Freezers, and Cryopreservation Systems. Liquid nitrogen storage provides extremely low temperatures for long-term preservation, while advanced cryopreservation systems are gaining importance for maintaining sample viability during freezing and thawing.
Market Opportunities
The expansion of biobanking infrastructure presents significant opportunities for frozen tissue sample providers. Increasing investment in biological repositories can improve sample availability and support research across oncology, genetics, drug development, and precision medicine.
Emerging markets provide another opportunity as healthcare infrastructure, biotechnology capabilities, and research investment expand. Establishing localized storage and distribution networks can improve access to biological samples while reducing logistics challenges.
Advanced bioinformatics and digital pathology can create additional value by improving sample tracking, analysis, and integration of tissue-derived data. Partnerships with biotechnology companies focused on personalized medicine can further expand commercial opportunities.
Recent Developments and Market Trends:
Thermo Fisher Scientific announced in February 2025 the acquisition of Tissue Solutions Ltd., a UK-based biobank, to expand its global frozen tissue storage capabilities and standardize sample quality control across Europe.
Labcorp announced a strategic partnership with BioIVT in November 2024 to provide access to high-quality frozen tissue samples and strengthen preclinical research capabilities.
BioIVT introduced its CryoSpec frozen tissue sample processing platform in March 2025, targeting faster sample accession, quality control, and delivery for pharmaceutical customers.
The market is increasingly adopting integrated sample-management systems that combine inventory tracking, sample data, and preservation workflows, improving operational efficiency and traceability.
Growing emphasis on ethical sourcing, standardized sample management, digital pathology, and improved cryopreservation is reshaping the market as researchers demand higher-quality and more reliable biological specimens.
Reasons to Buy the Report:
Understand the market size, 4.4% CAGR, forecast trajectory, regional outlook, application landscape, and competitive environment of the global Frozen Tissue Samples Market.
Evaluate opportunities across Cancer Research, Genetic Research, Drug Development, and Diagnostic Applications and identify the segments driving market expansion.
Assess demand across academic institutions, pharmaceutical companies, biotechnology companies, and clinical research organizations, along with key sample types and storage technologies.
Identify emerging opportunities associated with biobanking, personalized medicine, genomics, advanced cryopreservation, digital pathology, and bioinformatics-enabled sample management.
Gain competitive intelligence on major market participants, strategic developments, technological advances, regional opportunities, and evolving biological-sample preservation trends.
Future Outlook
The Frozen Tissue Samples Market is expected to maintain steady growth through 2035 as biobanking, oncology research, genomics, personalized medicine, and pharmaceutical development continue to increase demand for high-quality biological specimens. The market is projected to reach USD 3.0 billion by 2035 at a 4.4% CAGR.
North America is expected to remain the dominant regional market because of its advanced healthcare infrastructure and substantial biomedical research investment. Asia-Pacific is positioned for faster expansion as healthcare expenditure, biopharmaceutical activity, and awareness of biobanking increase.
Future development is likely to focus on improved cryopreservation, automated storage, integrated sample-management platforms, ethical and standardized sourcing, digital pathology, and genomics-enabled research. These technologies should strengthen the role of frozen tissue samples in precision medicine and next-generation biomedical research.
